Research Progress of Granulocyte Colony Stimulating Factor in the Treatment of Liver Failure

Corresponding author: Zhaoxiaofang, 1105320747@qq.com

DOI: 10.12201/bmr.202505.00003

•  

  Abstract: Liver failure is a high-risk and high-mortality disease, and its pathogenesis is not yet fully understood. As an important cytokine, granulocyte-colony stimulating factor (G-CSF) has an important role in the clinical treatment of liver failure. The aim of this review is to summarize and analyze the research progress in recent years on the mechanism of G-CSFs role in liver failure, including its effects on hepatocyte regeneration, immunomodulation, survival improvement, and safety of clinical use.

  Key words: Granulocyte colony-stimulating factor; Liver failure; Hepatocyte regeneration; Regulation of immunity

  Submit time: 9 May 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor combined with bifidobacterium in treatment of oral mucositis after chemotherapy
  Lan? Qinghua 1, Zeng Qingfang 1, Xiao Wei 2, Zhan Tao 1,Zhong Jianming 1, Qiu Liujin 1. 2025. doi: 10.12201/bmr.202505.00045

  wangminggang, luojuan, mozhengyuan, chenxinxin, wangxiufeng. The Role of Immune Cells and Traditional Chinese Medicine in Acute-on-Chronic Liver Failure. 2025. doi: 10.12201/bmr.202504.00030

  Zhulei. Research Progress on Drug-induced Liver Injury with Immune Characteristics. 2025. doi: 10.12201/bmr.202504.00001

  WU Xiayang. The mechanisms of action of SGLT2i in the treatment of heart failure and recent research advances. 2025. doi: 10.12201/bmr.202507.00052

  wang zhong. Plasma C1q/ tumor necrosis factor-associated protein 6 and systemic inflammatory response index levels in patients with heart failure and their clinical significance. 2025. doi: 10.12201/bmr.202501.00060

  LI JIE. Research Advances in Heart Failure with Preserved Ejection Fraction Complicated by Chronic Kidney Disease. 2025. doi: 10.12201/bmr.202504.00077

  XIE Wei, WANG Ruoyu, PENG Jianping, ZHAN Tao, CHEN Bin, WU Yunan. Prognostic predictive value of indocyanine green 15-minute retention rate combined with plasma ammonia and end-stage liver disease model score in patients with HBV-associated slow plus acute liver failure. 2025. doi: 10.12201/bmr.202507.00064

  CHENG Ke, XU Shucai. Progress in the treatment of blood hypercoagulability in patients with non-small cell lung cancer. 2025. doi: 10.12201/bmr.202506.00015

  liumiao, yuanfangxiu, wangling, zengqiongjuan, zhuyuzhen, tujiaojiao, wangjun. . 2024. doi: 10.12201/bmr.202408.00006

  HONG Liang, PAN Anna, WU Yanghe, YE Xiaoting. Esculin improve lipid accumulation in hepatocytes by inhibiting the PERK/eIF2A/ATF4 signaling pathway. 2024. doi: 10.12201/bmr.202409.00013

• ID	Submit time	Number	Download
  1	2025-02-25	10.12201/bmr.202505.00003V1	Download

• Public  Anonymous  To author only Submit Comments